Atorvastatin Calcium
Product Images NDC 68071-2441

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2441 6)

NuCare Pharmaceuticals, Inc. is a company that has manufactured Atorvastatin Calcium 20mg* tablets. The tablets come in a pack of 60 and are Lot 00000 with NDC number 68071-2441-06. Each film-coated tablet contains Atorvastatin Calcium USP equivalent to Atorvastatin 20mg. The tablets are oval-shaped, white or off-white, and imprinted with FF2 on one side. The expiration date is 00-00, and the lot number is 00000. Users may contact their doctor if they experience any side effects while consuming it. The product should be stored at a controlled temperature of 68-77°F and kept out of reach of children.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

The text represents a graph showing the cumulative hazard percentage (y-axis) over time to the first primary endpoint (x-axis) through four years of follow-up for a placebo group and a group taking Atorvastatin. The graph also displays the Hazard Ratio (HR), confidence interval, and p-value for the comparison between the two groups. No additional information is provided.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

The given text represents a statistical data on the effects of Atorvastatin in different dosages on the occurrence of major cardiovascular events. It shows that only 0.2% and 0.1% of the subjects experienced an event in the two different dosages of Atorvastatin, namely 10mg and 80mg, respectively. The data also indicates that Atorvastatin 80mg had a significant reduction (HR=0.78) in the occurrence of such events compared to Atorvastatin 10mg, with a p-value of 0.002. The graph provided shows the time to the occurrence of the first major cardiovascular endpoint over five years.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.